Your browser doesn't support javascript.
loading
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.
Leijen, Suzanne; Burgers, Sjaak A; Baas, Paul; Pluim, Dick; Tibben, Matthijs; van Werkhoven, Erik; Alessio, Enzo; Sava, Gianni; Beijnen, Jos H; Schellens, Jan H M.
Affiliation
  • Leijen S; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Invest New Drugs ; 33(1): 201-14, 2015 Feb.
Article in En | MEDLINE | ID: mdl-25344453
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2015 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2015 Document type: Article Affiliation country: Country of publication: